tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

TEVA Stock Latest News

Teva to Present at the Bank of America 2024 Global Healthcare Conference
Press ReleasesTeva to Present at the Bank of America 2024 Global Healthcare Conference
9d ago
TEVA
EU set to fine Teva for disparaging rival to Copaxone, Reuters reports
PremiumThe Fly
EU set to fine Teva for disparaging rival to Copaxone, Reuters reports
10d ago
TEVA
EU set to fine Teva for disparaging rival to Copaxone, Reuters reports
PremiumThe Fly
EU set to fine Teva for disparaging rival to Copaxone, Reuters reports
10d ago
TEVA
Teva case for multiple expansion ‘remains solid,’ says Jefferies
PremiumThe Fly
Teva case for multiple expansion ‘remains solid,’ says Jefferies
11d ago
TEVA
Teva provides update on Olanzapine LAI trial
PremiumThe Fly
Teva provides update on Olanzapine LAI trial
16d ago
TEVA
Teva price target raised to $26 from $24 at UBS
PremiumThe FlyTeva price target raised to $26 from $24 at UBS
17d ago
TEVA
Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
Premium
Press Releases
Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
25d ago
TEVA
Teva put volume heavy and directionally bearish
Premium
The Fly
Teva put volume heavy and directionally bearish
25d ago
TEVA
Teva put volume heavy and directionally bearish
PremiumThe Fly
Teva put volume heavy and directionally bearish
1M ago
TEVA
Teva price target raised to $22 from $21 at Barclays
PremiumThe Fly
Teva price target raised to $22 from $21 at Barclays
2M ago
TEVA
Teva reiterates FY27 revenue growth view up mid-single digits
PremiumThe Fly
Teva reiterates FY27 revenue growth view up mid-single digits
2M ago
TEVA
Teva sees FY24 free cash flow $1.7B-$2B
PremiumThe Fly
Teva sees FY24 free cash flow $1.7B-$2B
2M ago
TEVA
Teva raises 2024 revenue view $16M-$16.4M from $15.7M-$16.3M
PremiumThe FlyTeva raises 2024 revenue view $16M-$16.4M from $15.7M-$16.3M
2M ago
TEVA
Teva reports Q2 EPS 61c, consensus 55c
Premium
The Fly
Teva reports Q2 EPS 61c, consensus 55c
2M ago
TEVA
Teva Pharmaceutical Industries Limited (TEVA) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Teva Pharmaceutical Industries Limited (TEVA) Q2 Earnings Cheat Sheet
2M ago
TEVA
Teva put volume heavy and directionally bearish
PremiumThe Fly
Teva put volume heavy and directionally bearish
2M ago
TEVA
Teva, Sanofi announce accelerated timeline for duvakitug program
PremiumThe Fly
Teva, Sanofi announce accelerated timeline for duvakitug program
2M ago
SNY
TEVA
Teva put volume heavy and directionally bearish
PremiumThe Fly
Teva put volume heavy and directionally bearish
2M ago
TEVA
Axsome Therapeutics price target lowered to $95 from $97 at BofA
PremiumThe Fly
Axsome Therapeutics price target lowered to $95 from $97 at BofA
2M ago
AXSM
TEVA
Teva announces topline results from SPACE study
PremiumThe FlyTeva announces topline results from SPACE study
2M ago
TEVA
Teva put volume heavy and directionally bearish
Premium
The Fly
Teva put volume heavy and directionally bearish
2M ago
TEVA
Carvana upgraded, LegalZoom downgraded: Wall Street’s top analyst calls
Premium
The Fly
Carvana upgraded, LegalZoom downgraded: Wall Street’s top analyst calls
2M ago
V
LZ

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >